A61K 31/10
Sulfides
Official title: Sulfides; Sulfoxides; Sulfones
A61K31/10 (Sulfides) appears on 572 US grants and 891 published applications in this corpus.
Search patents in A61K- Granted patents
- 572
- Published applications
- 891
- Assignees
- 511
- Inventors
- 1,779
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 5 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 4 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 2 | 0 |
| 1986 | 3 | 0 |
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 13 | 0 |
| 1990 | 11 | 0 |
| 1991 | 11 | 0 |
| 1992 | 10 | 0 |
| 1993 | 9 | 0 |
| 1994 | 5 | 0 |
| 1995 | 7 | 0 |
| 1996 | 4 | 0 |
| 1997 | 13 | 0 |
| 1998 | 10 | 0 |
| 1999 | 12 | 0 |
| 2000 | 8 | 0 |
| 2001 | 13 | 4 |
| 2002 | 7 | 9 |
| 2003 | 8 | 19 |
| 2004 | 7 | 31 |
| 2005 | 6 | 19 |
| 2006 | 9 | 13 |
| 2007 | 3 | 22 |
| 2008 | 4 | 28 |
| 2009 | 7 | 20 |
| 2010 | 5 | 49 |
| 2011 | 5 | 41 |
| 2012 | 15 | 32 |
| 2013 | 26 | 42 |
| 2014 | 21 | 43 |
| 2015 | 28 | 54 |
| 2016 | 37 | 42 |
| 2017 | 33 | 58 |
| 2018 | 32 | 39 |
| 2019 | 38 | 54 |
| 2020 | 26 | 47 |
| 2021 | 20 | 42 |
| 2022 | 24 | 47 |
| 2023 | 17 | 39 |
| 2024 | 16 | 41 |
| 2025 | 15 | 33 |
| 2026 | 8 | 23 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compounds for inhibition of inflammation25 Aug 2026US 12,714,716 B2Children's Medical Center Corporation
- Botanicals as WNT/beta-catenin activators, molecular pathway regulators, tissue regenerators and health biomarker regulators18 Aug 2026US 12,708,655 B2Arbor Life Holdings, Ltd.
- Urea, amide, and substituted heteroaryl compounds for CBL-B inhibition16 Jun 2026US 12,653,809 B2Nurix Therapeutics, Inc.
- Devices and method for prevention and treatment of fungal and bacterial microorganisms16 Jun 2026US 12,654,025 B2Zero Candida Ltd.
- Antifungal compositions26 May 2026US 12,635,689 B2University of Exeter
- Glycopyrrolate salts24 Sep 2026US 2026/0284007 A1Journey Medical Corporation
- Methods for developing companion supplements for dogs, related compositions, and systems17 Sep 2026US 2026/0272876 A1Life's Abundance
- Inhibitors of ca 2+/calmodulin-dependent protein kinase ii (camkii) that do not inhibit long-term potentiation (ltp) induction and therapeutic uses thereof10 Sep 2026US 2026/0263429 A1The Regents of the University of Colorado, a body corporate
- Acetaminophen compositions and methods of treating cancer3 Sep 2026US 2026/0256720 A1The United States Government as represented by the Department of Veterans Affairs
- Dietary supplement for managing stress-induced inflammatory skin disorders13 Aug 2026US 2026/0232612 A1Codex Labs Corporation
Most cited
By later US patents
- Compositions comprising hyaluronic acid and drugs122US 5,985,850 AHyal Pharmaceuticals Corporation · 1999
- Anti-estrogenic compounds and compositions119US 5,395,842 AEndorecherche, Inc. · 1995
- Topical treatment and composition90US 4,661,524 ABeecham Group Limited · 1987
- Compositions for treating corns and calluses70US 5,547,989 ASchering-Plough Healthcare Products, Inc. · 1996
- Method for preventing onset of hypertension employing a cholesterol lowering drug70US 5,593,971 AE. R. Squibb & Sons, Inc. · 1997